Optimization of industrial production of rifamycin B by Amycolatopsis mediterranei. I. The role of colony morphology and nitrogen sources in productivity

African Journal of Biotechnology

Volumn 3, Issue 5, 2004, Pages 266-272

  El Tayeb, O M ^a   Salama, A A ^a   Hussein, M M M ^a   El Sedawy, H F ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Amycolatopsis mediterranei; Biotechnology; Fermentation; Rifamycin B; Strain selection

Indexed keywords

NITROGEN; POTASSIUM NITRATE; RIFAMYCIN B; SULFUR DERIVATIVE;

AGAR MEDIUM; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM COLONY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MANUFACTURE; FERMENTATION MEDIUM; GRAM POSITIVE BACTERIUM; INCUBATION TIME; INDUSTRIAL PRODUCTION; INOCULATION; MICROSCOPY; MYCELIUM; NOCARDIA MEDITERRANEA; NONHUMAN; PRODUCTIVITY; YEAST;

AMYCOLATOPSIS MEDITERRANEI;

EID: 18944394735     PISSN: 16845315     EISSN: 16845315     Source Type: Journal    
DOI: 10.5897/ajb2004.000-2049     Document Type: Article

References (31)

1. Anne M, Sharon E, Michael H (2000). Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniaziderifampin therapy in a mouse tuberculosis model. Antimicrob. Agents. Chemother. 44: 3167-3168.
2. Anon (1999). Rifapentin-long-acting rifamycin for tuberculosis. Med. Lett. Drugs. Ther. 41: 21-22.
3. Bernfeld P (1955). Amylases alpha and beta. In: Keplan N(ed) Methods in Enzymology. Vol. 1, pp. 149-158.
4. De Cock KM, Chaisson RE (1999). Will DOTS do it. A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int. J. Tuberc. Lung Dis. 3: 457-465.
5. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999). Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 282: 677-686.
6. Farid MA, El-Diwany AI, El-Enshasy HA (1996). Selection and characterization of high producing rifamycins colony from Amycolatopsis mediterranei. Acta. Pharm. Turc. 38 (4): 91-100.
7. Fishman SE, Gershberger CL (1983). Amplified DNA in Streptomyces fradiae. J. Bacteriol. 155: 459-466.
8. Gresham R, Inamine E (1986). Nutritional improvement of process. In: Demain AL, Solomon NA (eds) Manual of Industrial Microbiology and Biotechnology. Washington: ASM, pp 41-48.
9. Kawaguchi T, Asahi T, Satoh T, Uozumi T, Beppu T (1984). B-factor, an essential regulatory substance inducing the production of rifamycin in a Nocardia sp. J. Antibiot. 37: 1587-1589.
10. Kawaguchi T, Azuma M, Horinouchi S, Beppu T (1988). Effect of B-factor and its analogous on rifamycin biosynthesis in Nocardia sp. J. Antibiot. 41: 360-365.
11. Keshavjee S, Bacerra MC (2000). Disintegrating health services and resurgent tuberculosis in post-Soviet Tajikistan: an example of structural violence. JAMA. 283: 1201.
12. Krishna PS, Venkateswarlu G, Venkateswar-Rao L (2000). Effect of uracil on rifamycin SV production by Amycolatopsis mediterranei MV35R. Lett. Appl. Microbiol. 31(1): 73-76.
13. Lal R, Khanna M, Hardeep K, Srivastava N, Tripathi KK Lal S (1995). Rifamycins: Strain improvement program. Crit. Rev. Microbiol. 21(1):19-30.
14. Lancini G, Cavalleri B (1997). Rifamycins. In: Strohl WR (ed) Biotechnology of Industrial Antibiotics. Marcel Decker, New York, pp.521-549.
15. Lancini GC, Sensi P (1967). Studies on the final steps in rifamycin biosynthesis. In: Spitzy KH, Haschek H (eds) Proceedings of the Fifth International Congress of Chemotherapy. Vol. 1. Wien: Verlog der Wiener Medizinischen Akademie, pp 41-47.
16. Le Chevalier MP, Prauser H, Labeda DP, Ruan JS (1986). Two new genera of nocardioform actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov. Int. J. Syst. Bacteriol. 36: 29.
17. Lee JG, Choi CY, Seong BL, Han MH (1983). Optimal pH profile in rifamycin B fermentation. Ferment. Technol. 61: 49-53.
18. Lee KJ, Rho YT (1994). Quantitative analysis of mycelium morphological characteristics and rifamycin B production using Nocardia mediterranei. J. Biotechnol. 36: 239-245.
19. Lysko AV, Gorskaia SV (1986). Effect of various forms of inorganic nitrogen on biosynthesis of rifamycin B. J. Antibiot. Med. Biotechnol. 31: 519-521.
20. Margalith P, Beretta G (1960). Rifamycin XI: Taxonomic study on Streptomyces mediterranei nov. sp. Mycopathol. Mycol. Appl. 13:321-330.
21. Mertz FP, Doolin LE (1973). The effect of inorganic phosphate on the biosynthesis of vancomycin. Can. J. Microbiol. 19: 263-270.
22. Ono H, Hintermann G, Crameri R, Wallis G, Hiitter R (1982). Reiterated DNA sequences in a mutant strain of Streptomyces glaucessens and cloning of the sequence in Escherichia coli. Mol. Gen. Genet. 186:106-110.
23. Pape H, Rehm HJ (1985). Microbial Products. In: Rehm HJ, Reed G (eds) Biotechnology. VCH, pp 436-457.
24. Pasqualucci CR, Vigevani A, Radaelli P, Gallo GG (1970). Improved differential spectrophotometric determination of rifamycins. J. Pharm. Sci. 59: 685-687.
25. Reynaldo- Dietze D, Lucileia T, Lia M, Canedo R, Moises P, John L, Johnson L, Charles W, Lynn R, Kathleen E, Jerrold JE (2001). Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis. Antimicrob. Agents Chemother. 45: 1972-1976.
26. Rho YT, Nam-Goong G, Lee RJ (1991). Rheological characteristics of rifamycin B fermentation using Nocardia mediterranei. J. Microbiol. Biotechnol. 1: 70-74.
27. th edition. Blackwell Scientific publications, Oxford, pp 91-129.
28. Schrempf H (1982). Plasmid loss and changes within the chromosomal DNA of Streptomyces reticuli. J. Bacteriol. 151: 701-707.
29. Sensi P, Thiemann JE (1967). Production of rifamycins. Prog. Ind. Microbiol. 6: 21-59.
30. Thiemann JE, Zucco G, Pelizza G (1969). A protoplast for the transfer of Streptomyces mediterranei to the genus Nocardia mediterranei. Comb. Nov. Arch. Microbiol. 67: 147-155.
31. WHO (2002). Report on infectious diseases. World Health Organization, Geneva, Switzerland.